Salmonella Typhi Test Peratop

$1.00

WhatsApp Order
The Salmonella typhi test peratop is a CE-marked rapid immunochromatographic assay for qualitative detection of IgG and IgM antibodies to Salmonella enterica serotype Typhi in human serum, plasma, or whole blood, providing results in 15-20 minutes. The test uses recombinant S. typhi antigens immobilized on a membrane to capture specific antibodies, with separate lines for IgG and IgM interpretation. The kit includes individually foil-wrapped test cassettes, sample diluent, disposable pipettes, and package insert. Primary clinical applications include rapid diagnosis of typhoid fever in endemic regions (Indian subcontinent, Southeast Asia, Africa, South America), differentiation of acute (IgM positive) from past infection (IgG only), outbreak investigation and control, screening in febrile patients, travel medicine assessment, antibiotic stewardship, and maternal/child health in endemic areas. Critical safety precautions include proper specimen handling (universal precautions), quality control verification, awareness of window period (repeat testing if early infection suspected), and clinical correlation of results. Essential rapid test for typhoid fever diagnosis in resource-limited and endemic settings.
Description

Salmonella Typhi Test Peratop

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Rapid Diagnosis of Typhoid Fever:
  • Primary Use: The Peratop Salmonella typhi test is a rapid immunochromatographic assay for qualitative detection of specific antibodies (IgG and IgM) to Salmonella enterica serotype Typhi in human serum, plasma, or whole blood, enabling rapid diagnosis of typhoid fever in patients presenting with prolonged fever, abdominal pain, headache, malaise, and other symptoms suggestive of enteric fever.
  • How it helps: Provides clinicians with a quick, reliable answer for patients suffering from prolonged fever in endemic areas, distinguishing typhoid from other common causes of fever like malaria, dengue, and respiratory infections, and enabling prompt, targeted antibiotic therapy.
2. Differentiation of Acute and Past Infection:
  • Primary Use: The test’s ability to detect both IgM and IgG antibodies helps distinguish between acute infection (IgM positive, with or without IgG) and past infection or vaccination (IgG positive only, IgM negative), guiding appropriate clinical management and treatment decisions.
  • How it helps: Helps doctors determine whether a patient’s positive result means they are currently infected and need treatment, or whether they have had typhoid in the past and are now immune, preventing unnecessary antibiotic use.
3. Outbreak Investigation and Control:
  • Primary Use: Used during suspected typhoid fever outbreaks for rapid case identification, facilitating immediate isolation, treatment, and public health interventions to prevent further transmission in communities, schools, and residential settings.
  • How it helps: Enables rapid response teams to identify and contain typhoid outbreaks quickly, tracing the source of infection—often contaminated food or water—and preventing the disease from spreading through communities.
4. Screening in Endemic Regions:
  • Primary Use: Employed in areas where typhoid fever is endemic (Indian subcontinent, Southeast Asia, Africa, South America) for rapid screening of febrile patients, helping distinguish typhoid from other common causes of fever such as malaria, dengue, leptospirosis, and respiratory infections.
  • How it helps: Provides a simple, affordable screening tool for busy clinics in endemic regions, helping healthcare workers make informed decisions about which patients need antibiotics and which need treatment for other conditions.
5. Travel Medicine and Post-Travel Assessment:
  • Primary Use: Used to evaluate patients returning from endemic regions with febrile illness, enabling rapid diagnosis and prompt initiation of appropriate antibiotic therapy to prevent complications such as intestinal perforation or septic shock.
  • How it helps: Offers returning travelers and their doctors peace of mind, quickly identifying whether a post-travel fever is caused by typhoid or another tropical illness, and guiding treatment before the infection becomes severe.
6. Antibiotic Stewardship:
  • Primary Use: Rapid results enable targeted antibiotic therapy, reducing unnecessary use of broad-spectrum antibiotics and helping combat the growing problem of antimicrobial resistance in typhoid management, particularly against multidrug-resistant strains.
  • How it helps: Ensures that precious antibiotics are used only when they are truly needed, helping preserve their effectiveness for future patients and slowing the spread of drug-resistant typhoid strains.
7. Maternal and Child Health in Endemic Areas:
  • Primary Use: Used to diagnose typhoid fever in pregnant women and children in endemic regions, where prompt treatment is essential to prevent maternal complications, fetal loss, and severe disease in pediatric populations.
  • How it helps: Protects the most vulnerable members of endemic communities—pregnant women and young children—by providing rapid diagnosis that allows for immediate treatment before the disease can cause serious harm.

SECONDARY & SUPPORTIVE USES

1. Food Handler Screening: Employed in some regions for screening food handlers to identify chronic carriers and prevent foodborne transmission of typhoid in restaurants, cafeterias, and food processing facilities.
2. Household Contact Tracing: Used to test close contacts of confirmed cases to identify asymptomatic carriers and prevent secondary transmission within households and close communities.
3. Vaccine Response Assessment: May be used to assess antibody response following typhoid vaccination (with appropriate interpretation), though not a primary indication.
4. Research and Epidemiological Studies: Utilized in studies investigating typhoid fever prevalence, risk factors, transmission patterns, and vaccine efficacy in endemic populations.
5. Migrant and Refugee Health Screening: Used to screen at-risk populations from endemic regions for typhoid carriage and infection during initial health assessments.
6. Clinical Trials for New Vaccines and Treatments: Employed in research settings to confirm typhoid infection in participants enrolled in vaccine efficacy trials or studies of new antimicrobial agents.
7. Community Health Worker Programs: Deployed in remote endemic areas for decentralized testing by trained community health workers, improving access to diagnosis in underserved populations.
KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

  • Product Type: Rapid immunochromatographic test for qualitative detection of antibodies to Salmonella enterica serotype Typhi.
  • Brand/Manufacturer: Peratop (Peratop GmbH, Germany).
  • Detection Targets: IgG and IgM antibodies to S. typhi.
  • Sample Types: Serum, plasma, or whole blood (fingerstick or venipuncture).
  • Test Time: 15-20 minutes.
  • Test Principle: Immunochromatography; recombinant S. typhi antigens immobilized on membrane capture specific antibodies in patient sample, forming visible lines.
  • Internal Control: Built-in procedural control line confirms test validity; no control line = invalid test.
  • Packaging Sizes: 10, 20, 25, or 50 tests per kit.
  • Shelf Life: 18-24 months from manufacture date.
  • Storage Temperature: 2-30°C; protect from humidity and direct sunlight; do not freeze.

2. TECHNICAL & PERFORMANCE PROPERTIES

  • Sensitivity: High (typically >95% compared to blood culture or reference methods).
  • Specificity: High (typically >95% with minimal cross-reactivity to other Salmonella serotypes or enteric pathogens).
  • Detection Window: IgM antibodies appear within 3-5 days of infection; IgG appears later and persists.
  • Interpretation of Results:
    • IgM Positive (+), IgG Positive or Negative: Indicates acute or recent infection.
    • IgM Negative, IgG Positive (+): Indicates past infection or vaccination.
    • IgM Negative, IgG Negative: No detectable antibodies; typhoid unlikely (consider window period).
  • Cross-Reactivity: Minimal with other Salmonella serotypes; validated against common febrile illnesses.
  • Prozone Effect: Rare; high antibody concentrations may cause false negatives (serial dilution if suspected).

3. PHYSICAL & OPERATIONAL PROPERTIES

  • Test Device: Plastic cassette with sample well and result window.
  • Kit Components:
    • Test Devices: Individually foil-wrapped with desiccant.
    • Sample Diluent/Buffer: For sample application and migration.
    • Disposable Pipettes: For sample transfer.
    • Lancets: For fingerstick blood collection (if included).
    • Package Insert: Instructions for use and interpretation.
    • Controls: Positive and negative controls available separately.
  • Sample Volume: 10-20 µL (serum/plasma) or 1-2 drops (whole blood).
  • Result Interpretation:
    • Negative: Only control line visible.
    • IgM Positive: Control + IgM line visible.
    • IgG Positive: Control + IgG line visible.
    • IgM and IgG Positive: Control + IgM + IgG lines visible.
    • Invalid: No control line visible.

4. SAFETY & COMPLIANCE ATTRIBUTES

  • Regulatory Status: CE marked for IVD use; may have other international registrations.
  • Quality Control: Built-in procedural control in each test; external controls recommended with each new lot.
  • Biohazard Precautions: All blood samples potentially infectious for HIV, hepatitis B/C, and other bloodborne pathogens.
  • Chemical Safety: Buffer contains preservatives; avoid contact with eyes and skin.
  • Disposal: Used tests and lancets disposed of as biohazardous waste; lancets in sharps container.
  • Storage: Store per manufacturer specifications; do not use expired tests.

5. STORAGE & HANDLING ATTRIBUTES

  • Storage Temperature: 2-30°C; do not freeze; protect from humidity and direct sunlight.
  • Sample Handling: Test fresh samples within 24 hours if stored at 2-8°C; freeze at -20°C for longer storage.
  • Test Preparation: Bring test device and samples to room temperature before testing.
  • Procedure:
    1. Remove the test device from the foil pouch; place on a flat surface.
    2. Add sample to sample well (follow package insert for volume).
    3. Add diluent/buffer as directed.
    4. Wait 15-20 minutes.
    5. Read results; do not interpret after 30 minutes.
  • Expiration: Never use tests beyond expiration date; results invalid.
  • Quality Control: Test external controls with each new lot and as required.

6. LABORATORY & CLINICAL APPLICATIONS

  • Primary Application: Rapid point-of-care diagnosis of typhoid fever in endemic regions, travel clinics, and outbreak settings.
  • Clinical Indications:
    • Prolonged fever (>3 days) in endemic areas or with travel history.
    • Suspected enteric fever with symptoms: fever, abdominal pain, headache, malaise, rose spots.
    • Outbreak investigation in communities or households.
    • Screening of contacts of confirmed cases.
  • Interpretation Guidelines:
    • IgM Positive: Suggests acute typhoid; initiate appropriate antibiotic therapy.
    • IgG Positive Only: May indicate past infection or vaccination; consider clinical presentation.
    • Negative: Does not rule out typhoid if tested early (window period); repeat in 5-7 days if suspicion remains.
  • Limitations: Cannot distinguish between infection and vaccination (IgG only); blood culture remains gold standard; false negatives possible in early infection.
SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

  • Biological Hazard: All blood samples potentially infectious; wear gloves and appropriate PPE.
  • Hand Hygiene: Wash hands thoroughly after handling specimens and test devices.
  • Sharps Safety: Dispose of lancets in sharps containers; never recap or reuse.
  • Quality Control: Always verify control line appears; no control line = invalid test.
  • Clinical Correlation: Results must be interpreted with clinical presentation and patient history.
  • Window Period Awareness: Negative results in early infection require repeat testing.
  • Storage Compliance: Store tests at recommended temperature; heat/humidity degrades components.
  • Expiration: Never use expired tests; accuracy compromised.

2. FIRST AID MEASURES

  • Needlestick/Sharps Injury: Wash area vigorously with soap and water; report immediately; follow institutional exposure protocol.
  • Blood Spill: Contain with absorbent material; disinfect area with 10% bleach solution.
  • Buffer Contact (Eyes): Flush eyes with copious water for 15 minutes; seek medical attention.
  • Buffer Ingestion: Contact poison control center; do not induce vomiting unless instructed.

3. FIRE FIGHTING MEASURES

  • Flammability: Plastic components and packaging are combustible.
  • Extinguishing Media: Use water, foam, CO₂, or dry chemical as appropriate.